Deficiency of menin results in multiple endocrine neoplasia 1 (45), but on the other hand, its inhibition effectively disrupts leukemogenic transcriptional networks, resulting in the synergistic killing of leukemia cells (121). This evidence concerns the gene MEN1 and multiple endocrine neoplasia type 1.